Market closedNon-fractional

Century Therapeutics/IPSC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Century Therapeutics

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Ticker

IPSC

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Philadelphia, United States

Employees

159

IPSC Metrics

BasicAdvanced
$189M
Market cap
-
P/E ratio
-$2.22
EPS
1.45
Beta
-
Dividend rate
$189M
1.45
12.438
12.051
24.876
26.122
-914.77%
-19.32%
-58.66%
98.492
0.81
0.81
-1.368
-76.63%
3.33%
-35.52%

What the Analysts think about IPSC

Analyst Ratings

Majority rating from 6 analysts.
Buy

IPSC Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-3,500.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$800K
300.00%
Net income
-$28M
-28.75%
Profit margin
-3,500.00%
-82.19%

IPSC Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 10.36%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.56
-$0.55
-$0.65
-$0.45
-
Expected
-$0.54
-$0.51
-$0.55
-$0.50
-$0.46
Surprise
2.89%
7.30%
17.27%
-10.36%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Century Therapeutics stock?

Century Therapeutics (IPSC) has a market cap of $189M as of July 06, 2024.

What is the P/E ratio for Century Therapeutics stock?

The price to earnings (P/E) ratio for Century Therapeutics (IPSC) stock is 0 as of July 06, 2024.

Does Century Therapeutics stock pay dividends?

No, Century Therapeutics (IPSC) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Century Therapeutics dividend payment date?

Century Therapeutics (IPSC) stock does not pay dividends to its shareholders.

What is the beta indicator for Century Therapeutics?

Century Therapeutics (IPSC) has a beta rating of 1.45. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Century Therapeutics stock

Buy or sell Century Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing